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Abstract 
Neuroblastoma is the most common extracranial solid tumor in childhood. Its presenting 
signs and symptoms may be highly variable, depending on the location of the primary 
tumor and its local or metastatic diffusion and, rarely, with paraneoplastic syndrome 
such as opsoclonus-myoclonus-ataxia syndrome and gastrointestinal disturbances, due 
to autoantibodies or to aberrant secretion of vasoactive intestinal peptide. Herein we 
describe a 10-month-old child with neuroblastoma presenting with a complex clinical 
picture characterized by acute kidney injury manifested by renal insufficiency and signs 
and symptoms of tubulointerstitial damage, with polyuria, polydipsia, glucosuria, 
aminoaciduria and hypochloremic metabolic alkalosis, and of glomerular damage with 
heavy proteinuria. Imaging study documented a suprarenal mass enveloping the aorta 
and its abdominal and renal ramifications and bilaterally renal veins. This clinical picture 
shows some analogies with the hyponatremic-hypertensive syndrome concerning the 
renovascular disease; however, in absence of systemic arterial hypertension, the heavy 
proteinuria and the polyuria could be explained by sectional increased intraglomerular 
pressure, due to local renal blood vessels constriction. Hypochloremic metabolic 
alkalosis probably developed because of local production of renin, responsible of renin-Case Rep Oncol 2011;4:400–405 
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angiotensin-aldosterone system activation, but above all because of chloride loss 
through sweating. The long lasting dehydration, due to vomiting, sweating and polyuria, 
caused prolonged prerenal failure evolving in proximal tubular damage manifestations. 
 
Introduction 
Neuroblastoma is the most common extracranial solid tumor in childhood and 
accounts for 7% of malignancies in patients younger than 15 years [1]. It originates from 
the sympathetic nervous system, and in particular from a developing and incompletely 
committed precursor cell derived from neural-crest tissues [2]. Neuroblastoma occurs 
sporadically in 98% of cases; a genetic defect is involved in the rare familial 
neuroblastoma. In the subset of cases of neuroblastoma presenting in the context of other 
congenital abnormalities of the neural crest, the association with a germline loss-of-
function mutation of homeobox gene PHOX2B has been demonstrated; on the other 
hand, familial neuroblastoma not associated with other congenital disorders of the neural 
crest arises from activating mutations of the anaplastic lymphoma kinase (ALK) 
oncogene, whose somatic mutations are, however, observed in sporadic cases of the 
disease [2]. Due to the widespread presence of the sympathetic nervous tissue in various 
body organs and apparatus, the presenting features of neuroblastoma may be variable, 
depending not only on the location of the primary tumor but also on the frequent 
metastases [1]. Systemic symptoms due to aberrant catecholamine excretion may be 
observed. Furthermore, in young children, neuroblastoma exceptionally manifests with 
paraneoplastic opsoclonus-myoclonus-ataxia (POMA) due to antineuronal nuclear (anti-
Hu) antibodies [3] which have also been associated with gastrointestinal disturbances, 
such as constipation, gut dismotility and paralytic ileus [4]. On the contrary, watery 
diarrhea due to aberrant vasoactive intestinal peptide secretion may be the presenting 
symptom in some cases of differentiated neuroblastoma [5]. 
Proteinuria is not part of the presenting features of childhood cancer. In patients with 
neuroblastoma it has been reported only in a 4-year-old boy with abdominal 
neuroblastoma [6]. We report a case where proteinuria was the initial reason for medical 
evaluation in a child with neuroblastoma. 
Case Report 
A 10-month-old girl was admitted to our hospital for investigations for nephrotic-range proteinuria. 
She was born to unrelated, Italian, healthy parents, by spontaneous delivery at the 38th week of an 
uncomplicated pregnancy; her birth weight was 3,110 g. Her growth and development were normal 
until the age of nine months, when she began vomiting, feeding poorly, sweating copiously, and losing 
weight. On admission, physical examination showed poor clinical conditions, with hypotonia and 
moderate dehydration. Her weight was 7,220 g (<3th percentile), reduced from having previously 
reached 8,450 g; her length was 68 cm; her body temperature was 37.5°C with a heart rate of 150 
beats/min and respiratory rate of 46 breaths/min; blood pressure was normal on repeated 
measurements (82/43 mm Hg). Complete blood cell count showed leukocytes 12,800/mm
3, red cell 
count 7,160,000/mm
3, hemoglobin 15.7 g/dl, platelets 501,000/mm
3. Blood urea nitrogen was 28 mg/dl 
(10.23 mmol/l), creatinine 1.5 mg/dl (132.60 μmol/l), glucose 92 mg/dl (5.1 mmol/l), AST 25 IU/l, ALT 
42 IU/l; total plasma protein level was 7.9 g/dl, with albumin 56.9% (4.2 g/dl), α1 7.3%, α2 21.3%, β1 
6.3%, β2 3.4%, γ 4.8%; uric acid was 8.5 mg/dl, sodium 138 mmol/l, potassium 3.2 mmol/l, chloride 88 
mmol/l, venous pH 7.55 with a partial pressure of carbon dioxide of 29.2 mm Hg (probably due to Case Rep Oncol 2011;4:400–405 
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crying and hyperventilation), bicarbonate 27.8 mmol/l and BE +4. The AT III activity was 100%, 
prothrombin activity 100% and aPTT 29 s, serum lactate dehydrogenase was 376 IU/l and ferritin 5.9 
μmol/l (normal value for age 7–140 μmol/l). She had polyuria and hypostenuria (diuresis 125 ml/kg/24 
h); urinalysis revealed nephrotic-range proteinuria (6,100 mg/24 h) with albuminuria 4,540 mg/24 h, 
urinary loss of IgG 107 mg/24 h, and A1 microglobulin 29.4 mg/24 h; mild glucosuria (39 mg/dl) and 
aminoaciduria were also found, without hematuria or casts; urinary pH was 7.5 and urinary density 
1,005. Urine culture was found sterile. Electrocardiogram revealed sinus tachycardia 180 beats/min; 
echocardiogram showed very mild concentric left ventricular hypertrophy, however, without 
pathological features. An endocrinologic evaluation revealed increased plasma renin (8 μg/l/h; reference 
range 1.0–4.5 μg/l/h) and aldosterone (4.83 nmol/l; reference range 0.1–0.8 nmol/l) levels, while cortisol 
and thyroid hormones were within the normal range; plasma erythropoietin was 42.6 mU/ml (reference 
range 3.7–37.5 mU/ml). Urinary excretion of vanillylmandelic acid was increased to 11 mg/24 h (1.57 
mg/kg/24 h; reference range 0.1–0.18 mg/kg/24 h), while catecholamines were in the normal range, 
except for the normetanephrine and noradrenaline, which were also elevated (normetanephrine 1,537 
μg/24 h, reference range 88–440 μg/24 h; noradrenaline 120 μg/24 h, reference range 0–10 μg/24 h). 
The ultrasound abdomen examination revealed a solid, suprarenal mass on the left side, sized 2 × 2 
cm; the right kidney showed slightly increased echogenicity on the upper side. Doppler ultrasonography 
showed no abnormal findings. High-resolution CT showed an abdominal mass sized 5 × 5.8 × 10.7 cm, 
localized between the vertebral bodies D9 and L3 and the aorta, enveloping the celiac tripod, the 
superior mesenteric artery and bilaterally the renal vessels. The upper half of the right kidney showed an 
area of reduced perfusion, while the left kidney showed abnormal tissue density. Adrenal glands were 
not identifiable in the context of the tumor mass, in which some calcifications were recognizable. 
Histopathology showed a tumor with a low grade of neuroblastic differentiation, with mitosis-
karyorrhexis index (<2%) and elevated mitotic activity. 
Discussion 
In this patient, the presenting signs and symptoms of neuroblastoma included severe 
dehydration, polyglobulia, tubulointerstitial damage with acute kidney injury and renal 
insufficiency, electrolyte and acid-base unbalancing and heavy glomerular proteinuria. 
Although diarrhea and dehydration may be observed at presentation of neuroblastoma, 
tubular alterations are definitely unusual. We have been able to identify only one case 
previously: a 4-year-old boy affected by neuroblastoma presenting with nephrotic 
syndrome has been described in 1979 and renal histology demonstrated membranous 
glomerulonephritis due to immune complex [6]. 
On the other hand, POMA syndrome and gastrointestinal disturbances are associated 
with anti-Hu antibodies [3], and furthermore, the development of immune complex has 
been demonstrated in mice with C1300 neuroblastoma tumors confirming the tendency 
of neuroblastoma to produce immunologic paraneoplastic diseases [7]. Nevertheless, in a 
recent study performed on a broad series of adults with solid tumors, the prevalence of 
rheumatic syndromes was only 2.65%, and none of them manifested nephropathy, which 
shows the exceptionality of those manifestations also in adult patients [8]. 
In our opinion, the physiopathology of the complex clinical picture of the case we 
describe herein is not ascribable to autoimmune pathogenesis, but rather to a 
hemodynamic mechanism, subsequently complicated by a series of other 
physiopathologic phenomena. The sequence by which the events presumably developed is 
illustrated in figure 1. The initial event was the development of the tumor mass from the 
adrenal glands and its extension upwards to envelope the great abdominal blood vessels 
and bilaterally the renal vessels. The meaningful feature is that the disruption of renal 
blood supply and the hemodynamic consequences have been different in the various areas Case Rep Oncol 2011;4:400–405 
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of renal tissue, as revealed by sonography and CT findings. So, local increased 
intraglomerular pressure could prime the development of the hyponatremic-hypertensive 
syndrome, characterized by glomerular hyperfiltration with proteinuria, polyuria, acid-
base and electrolyte unbalancing, as rarely described in children with renovascular 
systemic hypertension [9–11]. Although in those circumstances, as expected, the 
consequence of the proteinuria is the development of nephrotic syndrome, in other cases 
the plasma albumin inexplicably remains at a normal level, even in case of lasting and 
massive albuminuria, as in our patient [11–14]. We could speculate that the severe 
dehydration, following copious sweating, vomiting and polyuria, caused such 
hypovolemia with hemoconcentration that plasma albumin concentration persisted 
beyond the threshold of edema. Also the polyglobulia could be explained by the same 
mechanism, even if another factor could have been the increased production of 
erythropoietin, probably stimulated by local renal parenchyma hypoxia. Hypovolemia 
was also responsible for the mild activation of the renin-angiotensin-aldosterone system 
and perhaps for metabolic alkalosis with hypochloremia and hypokalemia, but the loss of 
chloride through sweating was likely the most important cause of this phenomenon. 
Hypovolemia and the disruption of local renal blood circulation caused acute kidney 
injury and the signs and symptoms of proximal tubular damage, as glucosuria and 
aminoaciduria. On the other hand, the profound hypochloremia was the cause of the 
metabolic alkalosis, instead of metabolic acidosis typically associated with proximal 
tubular damage. Increased vasoactive amine secretion from neuroblastoma is not 
infrequent, and may cause elevated, although usually not severe, hypertension. 
In conclusion, in our 10-month-old child, alteration of the renal function, at both the 
glomerular and tubular levels, were the presenting features of neuroblastoma, resulting 
from multiple pathogenic mechanisms. Our report furthermore emphasizes the high 
variability and various facets of the clinical manifestations of neuroblastoma. 
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Fig. 1. Sequence of the events causing the complex clinical picture. 
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